Eli Lilly Receivables 2010-2024 | LLY

Eli Lilly receivables for the quarter ending September 30, 2024 were $12.052B, a 16.29% increase year-over-year.

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.

Eli Lilly Receivables 2010-2024 | LLY

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B